AAPL   320.78 (+0.84%)
MSFT   182.12 (+0.17%)
FB   225.64 (-1.65%)
GOOGL   1,428.49 (+0.58%)
AMZN   2,411.93 (+0.06%)
NVDA   342.00 (+0.99%)
CGC   21.55 (+8.29%)
BABA   199.73 (-0.72%)
MU   46.85 (-5.28%)
GE   6.83 (-6.31%)
AMD   51.92 (-1.55%)
T   31.10 (-2.35%)
GILD   75.58 (+0.84%)
DIS   116.64 (-4.02%)
NFLX   415.60 (-1.02%)
BAC   25.00 (-3.77%)
BA   150.67 (+0.77%)
AAPL   320.78 (+0.84%)
MSFT   182.12 (+0.17%)
FB   225.64 (-1.65%)
GOOGL   1,428.49 (+0.58%)
AMZN   2,411.93 (+0.06%)
NVDA   342.00 (+0.99%)
CGC   21.55 (+8.29%)
BABA   199.73 (-0.72%)
MU   46.85 (-5.28%)
GE   6.83 (-6.31%)
AMD   51.92 (-1.55%)
T   31.10 (-2.35%)
GILD   75.58 (+0.84%)
DIS   116.64 (-4.02%)
NFLX   415.60 (-1.02%)
BAC   25.00 (-3.77%)
BA   150.67 (+0.77%)
AAPL   320.78 (+0.84%)
MSFT   182.12 (+0.17%)
FB   225.64 (-1.65%)
GOOGL   1,428.49 (+0.58%)
AMZN   2,411.93 (+0.06%)
NVDA   342.00 (+0.99%)
CGC   21.55 (+8.29%)
BABA   199.73 (-0.72%)
MU   46.85 (-5.28%)
GE   6.83 (-6.31%)
AMD   51.92 (-1.55%)
T   31.10 (-2.35%)
GILD   75.58 (+0.84%)
DIS   116.64 (-4.02%)
NFLX   415.60 (-1.02%)
BAC   25.00 (-3.77%)
BA   150.67 (+0.77%)
AAPL   320.78 (+0.84%)
MSFT   182.12 (+0.17%)
FB   225.64 (-1.65%)
GOOGL   1,428.49 (+0.58%)
AMZN   2,411.93 (+0.06%)
NVDA   342.00 (+0.99%)
CGC   21.55 (+8.29%)
BABA   199.73 (-0.72%)
MU   46.85 (-5.28%)
GE   6.83 (-6.31%)
AMD   51.92 (-1.55%)
T   31.10 (-2.35%)
GILD   75.58 (+0.84%)
DIS   116.64 (-4.02%)
NFLX   415.60 (-1.02%)
BAC   25.00 (-3.77%)
BA   150.67 (+0.77%)
Log in

NASDAQ:ADROAduro BioTech News Headlines

$3.31
+0.03 (+0.91 %)
(As of 05/28/2020 03:44 PM ET)
Add
Compare
Today's Range
$3.24
Now: $3.31
$3.54
50-Day Range
$2.49
MA: $2.98
$3.31
52-Week Range
$0.90
Now: $3.31
$4.04
Volume42,299 shs
Average Volume445,636 shs
Market Capitalization$267.58 million
P/E RatioN/A
Dividend YieldN/A
Beta0.3

Headlines

Aduro BioTech (NASDAQ ADRO) News Headlines

Source:
DateHeadline
Aduro Biotechs Shares March Higher, Can It Continue?Aduro Biotech's Shares March Higher, Can It Continue?
finance.yahoo.com - May 26 at 9:03 AM
Aduro Biotech (ADRO) Upgraded to Buy: What Does It Mean for the Stock?Aduro Biotech (ADRO) Upgraded to Buy: What Does It Mean for the Stock?
finance.yahoo.com - May 25 at 1:06 PM
Aduro BioTech Inc Forecasted to Post FY2020 Earnings of ($0.63) Per Share (NASDAQ:ADRO)Aduro BioTech Inc Forecasted to Post FY2020 Earnings of ($0.63) Per Share (NASDAQ:ADRO)
www.americanbankingnews.com - May 25 at 1:54 AM
Aduro BioTech Inc (NASDAQ:ADRO) Sees Significant Drop in Short InterestAduro BioTech Inc (NASDAQ:ADRO) Sees Significant Drop in Short Interest
www.americanbankingnews.com - May 20 at 10:30 AM
Aduro Biotech to Host Conference Call and Webcast Featuring BION-1301 Data Presented at the 57th ERA-EDTA Virtual CongressAduro Biotech to Host Conference Call and Webcast Featuring BION-1301 Data Presented at the 57th ERA-EDTA Virtual Congress
finance.yahoo.com - May 19 at 12:42 PM
 Analysts Expect Aduro BioTech Inc (NASDAQ:ADRO) Will Post Quarterly Sales of $3.24 Million Analysts Expect Aduro BioTech Inc (NASDAQ:ADRO) Will Post Quarterly Sales of $3.24 Million
www.americanbankingnews.com - May 19 at 3:02 AM
 Analysts Expect Aduro BioTech Inc (NASDAQ:ADRO) to Announce -$0.18 EPS Analysts Expect Aduro BioTech Inc (NASDAQ:ADRO) to Announce -$0.18 EPS
www.americanbankingnews.com - May 17 at 4:50 PM
Aduro BioTech Inc (NASDAQ:ADRO) Receives Average Recommendation of "Buy" from AnalystsAduro BioTech Inc (NASDAQ:ADRO) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - May 16 at 4:38 AM
Is Aduro Biotech (ADRO) Stock a Solid Choice Right Now?Is Aduro Biotech (ADRO) Stock a Solid Choice Right Now?
finance.yahoo.com - May 11 at 5:17 PM
New Forecasts: Heres What Analysts Think The Future Holds For Aduro Biotech, Inc. (NASDAQ:ADRO)New Forecasts: Here's What Analysts Think The Future Holds For Aduro Biotech, Inc. (NASDAQ:ADRO)
finance.yahoo.com - May 10 at 4:41 PM
New Forecasts: Here's What Analysts Think The Future Holds For Aduro Biotech, Inc. (NASDAQ:ADRO)New Forecasts: Here's What Analysts Think The Future Holds For Aduro Biotech, Inc. (NASDAQ:ADRO)
finance.yahoo.com - May 10 at 4:41 PM
Q2 2020 EPS Estimates for Aduro BioTech Inc Increased by Analyst (NASDAQ:ADRO)Q2 2020 EPS Estimates for Aduro BioTech Inc Increased by Analyst (NASDAQ:ADRO)
www.americanbankingnews.com - May 8 at 1:26 PM
Aduro Biotech, Inc. (NASDAQ:ADRO) Reported Earnings Last Week And Analysts Are Already Upgrading Their EstimatesAduro Biotech, Inc. (NASDAQ:ADRO) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates
finance.yahoo.com - May 6 at 6:33 AM
Aduro BioTech (NASDAQ:ADRO) Posts  Earnings Results, Beats Estimates By $0.05 EPSAduro BioTech (NASDAQ:ADRO) Posts Earnings Results, Beats Estimates By $0.05 EPS
www.americanbankingnews.com - May 5 at 3:16 PM
Oppenheimer Reiterates "Hold" Rating for Aduro BioTech (NASDAQ:ADRO)Oppenheimer Reiterates "Hold" Rating for Aduro BioTech (NASDAQ:ADRO)
www.americanbankingnews.com - May 5 at 1:12 AM
Aduro Biotech (ADRO) Reports Q1 Loss, Tops Revenue EstimatesAduro Biotech (ADRO) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 4 at 11:55 PM
Aduro Biotech EPS beats by $0.05, beats on revenueAduro Biotech EPS beats by $0.05, beats on revenue
seekingalpha.com - May 4 at 6:55 PM
Aduro Biotech Provides Business Update and Reports First Quarter 2020 Financial ResultsAduro Biotech Provides Business Update and Reports First Quarter 2020 Financial Results
finance.yahoo.com - May 4 at 6:55 PM
Aduro Biotech (ADRO) May Report Negative Earnings: Know the Trend Ahead of Q1 ReleaseAduro Biotech (ADRO) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
finance.yahoo.com - April 28 at 1:20 PM
Investors Who Bought Aduro BioTech (NASDAQ:ADRO) Shares Five Years Ago Are Now Down 93%Investors Who Bought Aduro BioTech (NASDAQ:ADRO) Shares Five Years Ago Are Now Down 93%
finance.yahoo.com - April 12 at 9:26 AM
Aduro Biotech (ADRO) Down 3.1% Since Last Earnings Report: Can It Rebound?Aduro Biotech (ADRO) Down 3.1% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - April 8 at 12:53 PM
Has Aduro Biotech (ADRO) Outpaced Other Medical Stocks This Year?Has Aduro Biotech (ADRO) Outpaced Other Medical Stocks This Year?
finance.yahoo.com - April 1 at 4:23 PM
Aduro Biotech (ADRO) Gains As Market Dips: What You Should KnowAduro Biotech (ADRO) Gains As Market Dips: What You Should Know
finance.yahoo.com - March 23 at 10:48 PM
Aduro: Float Like A Butterfly, Sting Like A BeeAduro: Float Like A Butterfly, Sting Like A Bee
seekingalpha.com - March 18 at 1:44 PM
Is Aduro Biotech (ADRO) Outperforming Other Medical Stocks This Year?Is Aduro Biotech (ADRO) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - March 16 at 2:33 PM
Aduros (ADRO) Earnings & Revenues Miss Estimates in Q4Aduro's (ADRO) Earnings & Revenues Miss Estimates in Q4
finance.yahoo.com - March 11 at 5:45 PM
Aduro Biotech (ADRO) Reports Q4 Loss, Lags Revenue EstimatesAduro Biotech (ADRO) Reports Q4 Loss, Lags Revenue Estimates
finance.yahoo.com - March 9 at 10:50 PM
Aduro Biotech Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial ResultsAduro Biotech Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
finance.yahoo.com - March 9 at 5:50 PM
Aduro Biotech (ADRO) Stock Moves -0.6%: What You Should KnowAduro Biotech (ADRO) Stock Moves -0.6%: What You Should Know
finance.yahoo.com - March 5 at 9:55 PM
Is Aduro Biotech (ADRO) Stock Outpacing Its Medical Peers This Year?Is Aduro Biotech (ADRO) Stock Outpacing Its Medical Peers This Year?
finance.yahoo.com - February 28 at 3:25 PM
Aduro Biotech to Present at the Cowen and Company 40th Annual Health Care ConferenceAduro Biotech to Present at the Cowen and Company 40th Annual Health Care Conference
finance.yahoo.com - February 24 at 5:34 PM
Aduro Biotech IncAduro Biotech Inc
www.bloomberg.com - February 24 at 12:13 AM
Aduro Biotech (ADRO) Upgraded to Strong Buy: Heres WhyAduro Biotech (ADRO) Upgraded to Strong Buy: Here's Why
www.nasdaq.com - February 19 at 5:47 PM
Aduro Biotech to Present at the 9th Annual SVB Leerink Global Healthcare ConferenceAduro Biotech to Present at the 9th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 19 at 12:46 PM
Aduro Biotech (ADRO) Upgraded to Strong Buy: Here's WhyAduro Biotech (ADRO) Upgraded to Strong Buy: Here's Why
finance.yahoo.com - February 19 at 12:46 PM
29 Stocks Moving In Thursdays After-Hours Session29 Stocks Moving In Thursday's After-Hours Session
www.benzinga.com - February 6 at 6:12 PM
Aduro Biotech Announces Milestone Achieved under Merck Collaboration for Initiation of Phase 2 Trial of Anti-CD27 Agonist MK-5890 in Non-Small Cell Lung CancerAduro Biotech Announces Milestone Achieved under Merck Collaboration for Initiation of Phase 2 Trial of Anti-CD27 Agonist MK-5890 in Non-Small Cell Lung Cancer
finance.yahoo.com - February 6 at 6:12 PM
Aduro adds to rally as bargain hunters move in, shares up 18%Aduro adds to rally as bargain hunters move in, shares up 18%
seekingalpha.com - January 31 at 2:02 PM
Aduro to cut 59% of workforce in restructuringAduro to cut 59% of workforce in restructuring
seekingalpha.com - January 9 at 8:43 PM
Aduro Biotech Announces Corporate RestructuringAduro Biotech Announces Corporate Restructuring
finance.yahoo.com - January 9 at 8:43 PM
Novartis bails on Aduros ADU-S100Novartis bails on Aduro's ADU-S100
seekingalpha.com - December 17 at 6:11 PM
Hedge Funds Are Betting On Aduro BioTech Inc (ADRO)Hedge Funds Are Betting On Aduro BioTech Inc (ADRO)
finance.yahoo.com - December 14 at 6:02 PM
Does Aduro BioTech, Inc. (NASDAQ:ADRO) Have A Volatile Share Price?Does Aduro BioTech, Inc. (NASDAQ:ADRO) Have A Volatile Share Price?
finance.yahoo.com - December 9 at 6:15 AM
Aduro Biotech (ADRO) Up 7.5% Since Last Earnings Report: Can It Continue?Aduro Biotech (ADRO) Up 7.5% Since Last Earnings Report: Can It Continue?
finance.yahoo.com - December 7 at 3:50 PM
Aduro Biotech Announces Presentation of Results...Aduro Biotech Announces Presentation of Results...
www.benzinga.com - November 8 at 5:36 PM
Aduro Biotech Announces Presentation of Results from First-in-Human Phase 1 Study of Anti-CD27 Agonist as Monotherapy and in Combination with Pembrolizumab in Patients with Advanced Solid Tumors at the Society for Immunotherapy of Cancer 34th Annual MeetingAduro Biotech Announces Presentation of Results from First-in-Human Phase 1 Study of Anti-CD27 Agonist as Monotherapy and in Combination with Pembrolizumab in Patients with Advanced Solid Tumors at the Society for Immunotherapy of Cancer 34th Annual Meeting
finance.yahoo.com - November 8 at 5:36 PM
Aduro Biotech (ADRO) Reports Q3 Loss, Tops Revenue EstimatesAduro Biotech (ADRO) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 8 at 12:29 AM
BRIEF-Aduro Biotech Posts Q3 Loss Per Share Of $0.26BRIEF-Aduro Biotech Posts Q3 Loss Per Share Of $0.26
www.msn.com - November 7 at 7:29 PM
Aduro Biotech EPS misses by $0.03, beats on revenueAduro Biotech EPS misses by $0.03, beats on revenue
seekingalpha.com - November 7 at 7:29 PM
Aduro Biotech Provides Business Update and Reports Third Quarter 2019 Financial ResultsAduro Biotech Provides Business Update and Reports Third Quarter 2019 Financial Results
finance.yahoo.com - November 7 at 7:29 PM
This page was last updated on 5/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.